Aliskiren and Nirmatrelvir: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Aliskiren
Nirmatrelvir
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased aliskiren exposure
Interaction Deep Dive
Concomitant use of aliskiren and nirmatrelvir/ritonavir increases aliskiren exposure, therefore, coadministration should be avoided1. Withhold aliskiren during nirmatrelvir/ritonavir treatment and for 2 to 3 days (or longer in certain cases such as advanced patient age) after discontinuation if possible. Consider treatment with an alternative concomitant drug or COVID-19 treatment if temporarily withholding aliskiren is not clinically reasonable 2.
Why it happens (mechanism)
An unknown mechanism
Common questions
Can I take Aliskiren and Nirmatrelvir together?
Increased aliskiren exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Aliskiren and Nirmatrelvir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Aliskiren or Nirmatrelvir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: PAXLOVID(TM) oral tablets, nirmatrelvir oral tablets, ritonavir oral tablets. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
- COVID-19 Treatment Guidelines Panel: Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health (NIH). Bethesda, MD. 2023.
Keep reading about Aliskiren
Keep reading about Nirmatrelvir
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist